Stability of extemporaneous rifampicin prepared with X-temp® oral suspension system
Journal of Pharmacy · 2021
DOI: 10.31436/jop.v1i1.42 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Pharmacy, 2021. Verfasst von Salma Nadirah Md Salim und 2 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Introduction
Rifampicin is a first line antituberculosis drug that is commonly used in the treatment of tuberculosis, both in adults and paediatric patients. However, there is a lack of liquid formulation for rifampicin in the market due to the small market size and the physicochemical properties of the drug itself. An innovative new mix called X-Temp® oral suspension system (OSS) has been available in the market as a choice of vehicle for extemporaneous suspension.
Aim
The aim of this study was to prepare rifampicin suspension in the X-Temp® OSS and evaluate its stability following storage at two temperatures – refrigerated (5 °C ± 3 °C) and in a stability chamber (30 °C ± 2 °C/RH 75% ± 5%). Materials and method: This study investigates the physicochemical and microbiological stability of rifampicin formulated in X-temp® OSS. The rifampicin suspension was prepared at 25mg/ml and kept in two types of amber-coloured storage bottles. The bottles were stored in an open and close storage system at 5 oC (refrigeration) and 30 °C/75% RH (non-refrigerated) and the stability of the product was evaluated at specified time intervals.
Results
It was found that the content of rifampicin remained above 90% of the original concentration throughout the study as required by the standard references. Visual appearance, colour, odour and pH remained unchanged throughout the study period and the extemporaneous preparation was not susceptible to microbial contamination.
Conclusion
Results from this stability study confirmed that the X-temp® OSS is a suitable vehicle for the preparation of extemporaneous rifampicin liquid formulation.
Zitieren
APA
Salim, S. N. M., Murshid, M. D. M., & Gazzali, A. M. (2021). Stability of extemporaneous rifampicin prepared with X-temp® oral suspension system. Journal of Pharmacy. https://doi.org/10.31436/jop.v1i1.42
Vancouver
Salim SNM, Murshid MDM, Gazzali AM. Stability of extemporaneous rifampicin prepared with X-temp® oral suspension system. Journal of Pharmacy. 2021. doi:10.31436/jop.v1i1.42
BibTeX
@article{Salim2021,
author = {Salim, Salma Nadirah Md and Murshid, Mohd Danial Mohd and Gazzali, Amirah Mohd},
title = {Stability of extemporaneous rifampicin prepared with X-temp® oral suspension system},
journal = {Journal of Pharmacy},
year = {2021},
doi = {10.31436/jop.v1i1.42}
}
EUVIMED